Concall Intelligence
Follow the Sept 2026 quarter results season by comparing what companies reported with what management said next. Search official call evidence, measurable guidance, changing outlook, operating risks, and prior commitments without treating commentary as a trading recommendation.
Management evidence
Generated 5 Nov, 5:56 am IST · click a summary to inspect source-linked evidence for this results quarter.
| Company | Call and sources | Reported result | Management outlook | Evidence-led conclusion | Review |
|---|---|---|---|---|---|
| NYKAA FSN E-Commerce Ventures Limited Consumer · Mid | Sept 2026 4 Nov 2026 Preliminary brief | Excellent 100/100 | Optimistic outlook No comparable prior call No measurable guidance | FSN E-Commerce Ventures Limited (Nykaa) delivered a robust financial performance for Q2FY27, characterized by accelerating revenue growth of 28% YoY to Rs 3,006 Cr and a sharp surge in PAT by 207% YoY to Rs 101.2 Cr. Both core verticals, Beauty and Fashion, demonstrated strong operating leverage, efficiency gains, and network expansion, supported by strategic brand acquisitions such as Simply Nam and partnerships like L'Oreal BOLD. Evidence summary ready | |
| JSWDULUX JSW Dulux Limited Chemicals · Small | Sept 2026 4 Nov 2026 Preliminary brief | Bad 0/100 | Optimistic outlook No comparable prior call No measurable guidance | JSW Dulux Limited reported Q2 FY27 revenue of 961.9 Cr, reflecting a 15.2% YoY growth, driven by double-digit volume growth (+22%) and festive demand. However, margins were compressed due to raw material inflation and trade disruptions affecting TiO2 prices, leading to a statutory PAT decline of -95.8% YoY (though comparable growth was 2%). Evidence summary ready | |
| SBCL Shivalik Bimetal Controls Limited Metals · Small | Sept 2026 4 Nov 2026 Preliminary brief | Excellent 85/100 | Optimistic outlook No comparable prior call No measurable guidance | The investment thesis remains intact. SBCL continues to deliver robust earnings growth, margin expansion, and high operating leverage, driven by structural demand from domestic smart meters and shunts. While export headwinds persist in the Americas, strong traction in Asia and Europe, along with strategic forward integration into PCBA and busbars via the Pune facility, support long-term secular drivers. Evidence summary ready | |
| CLEANMAX Clean Max Enviro Energy Solutions Limited Power · Small | Sep 2026 4 Nov 2026 Preliminary brief | Excellent 90/100 | Optimistic outlook No comparable prior call No measurable guidance | The growth thesis remains intact backed by strong operational capacity expansion, robust demand from Data & AI customers, repeat business shares above 80%, and conservative leverage parameters. Evidence summary ready | |
| UTKARSHBNK Utkarsh Small Finance Bank Limited Consumer · Small | Sept 2026 4 Nov 2026 Preliminary brief | Average 30/100 | Neutral outlook No comparable prior call No measurable guidance | Management claims portfolio de-risking and asset quality stabilization are underway through a shift toward secured lending and digital collections. However, elevated credit costs and stress in the legacy JLG portfolio weigh on near-term profitability. Evidence summary ready | |
| TORNTPOWER Torrent Power Limited Power · Large | Sept 2026 4 Nov 2026 Preliminary brief | Average 52/100 | Optimistic outlook No comparable prior call No measurable guidance | Torrent Power Limited reported robust financial results for Q2 FY 2026-27 with consolidated revenue of Rs 9,802 crore, up 24% YoY, and profit after tax of Rs 838 crore, up 13% YoY. Growth is supported by a mix of licensed and franchised distribution assets with low AT&C losses, alongside expanding renewable and pumped storage energy pipelines. Evidence summary ready | |
| ORKLAINDIA Orkla India Limited FMCG · Micro | Sept 2026 4 Nov 2026 Preliminary brief | Average 52/100 | Optimistic outlook No comparable prior call No measurable guidance | Orkla India delivered high teens revenue growth of 19.4% YoY in Q2 FY27, supported by a 25.1% YoY surge in the spices category and pricing actions. However, volume growth remained modest at 2.9%, and EBITDA margin compressed by 100 bps YoY to 15.9% due to rising input costs and Project Bolt investments. Evidence summary ready | |
| LUPIN Lupin Limited Pharma · Mid | Sep 2026 4 Nov 2026 Preliminary brief | Bad 0/100 | Optimistic outlook No comparable prior call No measurable guidance | Lupin reported solid net sales of INR 77,855 mn for Q2 FY27 (up 14% YoY), driven by strong performance in India and Emerging Markets, alongside healthy EBITDA margins of 25.1%. However, net income dropped 21.8% YoY due to a high base effect from prior period operating income, and ongoing regulatory remediation at key manufacturing facilities remains a critical operational focus. Evidence summary ready | |
| GSPLTRANS GSPL Transmission Limited Energy · Micro | Sep 2026 4 Nov 2026 Preliminary brief | Pending data 0/100 | Optimistic outlook No comparable prior call No measurable guidance | The investment thesis remains intact. GTL benefits from regulated asset-backed returns, a debt-free balance sheet with INR 7,150 crores of total equity, and structural gas consumption tailwinds in Gujarat. Volume growth across all grid segments supports steady top-line expansion, while a ~INR 3,500 crore capex plan provides a clear runway for capacity additions. Evidence summary ready | |
| BSE BSE Limited Financial Services · Mid | Sept 2026 4 Nov 2026 Preliminary brief | Excellent 90/100 | Optimistic outlook No comparable prior call No measurable guidance | BSE Limited demonstrated robust financial performance in H1 FY27, driven by strong activity across transaction charges, corporate services, and investment income, leading to a consolidated net profit of Rs. 8,075 million for the quarter ended September 30, 2026. Evidence summary ready | |
| KTKBANK The Karnataka Bank Limited Financial Services · Micro | Sep 2026 4 Nov 2026 Transcript verified | Excellent 75/100 | Optimistic outlook No comparable prior call Guidance maintained | Karnataka Bank reported robust performance in Q2FY27 with PAT growing 36.6% YoY to Rs 435.9 crore and aggregate business crossing Rs 2,07,132 crore. Management remains focused on RAM growth, cost-of-funds optimization, and asset-quality improvements despite macro and global headwinds. Evidence summary ready | |
| MGL Mahanagar Gas Limited Energy · Large | Sept 2026 4 Nov 2026 Preliminary brief | Bad 2/100 | Neutral outlook No comparable prior call No measurable guidance | Mahanagar Gas Limited reported a decline in profitability for Q2 FY27 with PAT dropping 29.1% YoY to Rs 137.04 Crore, driven by higher gas costs and lower EBITDA margins, despite a 23.8% increase in net revenues. Evidence summary ready | |
| INDSWFTLAB Ind-Swift Laboratories Limited Pharma · Small | Sep 2026 4 Nov 2026 Preliminary brief | Excellent 100/100 | Optimistic outlook No comparable prior call No measurable guidance | The company's transition to a focused finished dosage formulation manufacturer is progressing, with strong sequential and year-on-year expansion in revenue and profitability. Margins are benefiting from a favorable business mix and operating leverage, while a net-debt-free balance sheet supports ongoing capital expenditure plans. Evidence summary ready | |
| AARTIDRUGS Aarti Drugs Limited Pharma · Micro | Sept 2026 4 Nov 2026 Preliminary brief | Excellent 100/100 | Optimistic outlook No comparable prior call No measurable guidance | Aarti Drugs Limited reported a strong financial performance for Q2 FY27, marked by record-high operational revenue of Rs. 829 crore and an EBITDA of Rs. 138 crore, supported by volume growth, better realizations, and operational integration. Evidence summary ready | |
| WELCORP Welspun Corp Limited Industrials · Small | Sept 2026 4 Nov 2026 Preliminary brief | Good 60/100 | Optimistic outlook No comparable prior call Guidance maintained | Welspun Corp reported robust H1FY27 performance with revenue of Rs. 8,725 cr and EBITDA of Rs. 1,538 cr, alongside a historic all-time high order book of ~Rs. 50,000 cr. However, domestic ductile iron pipe demand faces severe stress due to Jal Jeevan Mission funding constraints. Evidence summary ready | |
| DATAMATICS Datamatics Global Services Limited IT · Small | Sept 2026 4 Nov 2026 Preliminary brief | Good 70/100 | Optimistic outlook No comparable prior call No measurable guidance | Datamatics Global Services delivered a strong financial performance for Q2FY27, supported by broad-based revenue growth across segments and margin expansion, underpinned by robust net cash and ongoing AI-driven product adoption. Evidence summary ready | |
| SUNPHARMA Sun Pharmaceutical Industries Limited Pharma · Large | Sep 2026 4 Nov 2026 Transcript verified | Bad 0/100 | Optimistic outlook No comparable prior call Guidance maintained | Sun Pharmaceutical Industries Limited reported a robust performance in Q2 FY27 with consolidated sales of INR16,100 crore, up 11.8% YoY, and an EBITDA margin of 29.3%. Growth was led by a strong India formulations business and favorable product/currency mix, though US specialty growth faced headwinds from an Ilumya sales slowdown and lower lenalidomide sales compared to the base quarter. Evidence summary ready | |
| ZYDUSLIFE Zydus Lifesciences Limited Pharma · Large | Sept 2026 4 Nov 2026 Preliminary brief | Bad 0/100 | Optimistic outlook No comparable prior call No measurable guidance | Zydus Lifesciences reported strong revenue growth of 29.2% YoY to Rs. 7,909.6 Cr for Q2 FY27, driven by strong performances in India Formulations, North America, and Consumer Wellness. However, profitability contracted with PAT declining 25.1% YoY (reported PAT at Rs. 927.7 Cr) and EBITDA margin compressing to 23.9% due to higher operational expenses, depreciation, and finance costs. Evidence summary ready | |
| ACMESOLAR Acme Solar Holdings Limited Power · Large | Sept 2026 4 Nov 2026 Transcript verified | Good 67/100 | Optimistic outlook No comparable prior call Guidance raised | ACME Solar Holdings reported robust financial performance for Q2 FY27 with revenue of INR1,007 crores and PAT of INR269 crores, driven by BESS operations and capacity additions, despite ongoing transmission and GNA delays. Evidence summary ready | |
| HARSHA Harsha Engineers International Limited Industrials · Small | Sept 2026 4 Nov 2026 Preliminary brief | Excellent 80/100 | Optimistic outlook No comparable prior call No measurable guidance | The core India engineering business displays robust growth (24.1% YoY in Q2) and margin expansion driven by raw material pass-through and demand. While international operations in Romania remain challenged, management is executing downsizing and cost actions, and Harsha Advantek is expected to turn PAT positive in H2. Evidence summary ready | |
| RPPL Rajshree Polypack Limited Industrials · Small | Sept 2026 4 Nov 2026 Preliminary brief | Average 32/100 | Neutral outlook No comparable prior call No measurable guidance | Management continues to execute well on capacity expansion, particularly scaling up asset-light injection molding and increasing value-added product shares. Despite headwinds in raw material prices and geopolitical disruptions affecting exports, domestic growth remains resilient, maintaining operating margins around 12.69%. Evidence summary ready | |
| APLLTD Alembic Pharmaceuticals Limited Pharma · Mid | Sept 2026 4 Nov 2026 Preliminary brief | Excellent 100/100 | Optimistic outlook No comparable prior call No measurable guidance | Alembic Pharmaceuticals reported a strong performance for Q2 FY27, characterized by 36% YoY revenue growth to INR 26.03 bn and an 81% YoY jump in PAT to INR 3.35 bn, driven by robust momentum across US formulations, the India branded business, and API segments. Evidence summary ready | |
| RAYMONDLSL Raymond Lifestyle Limited Textiles · Micro | Sept 2026 4 Nov 2026 Transcript verified | Bad 0/100 | Optimistic outlook No comparable prior call Guidance maintained | Raymond Lifestyle Limited demonstrated solid operational resilience in Q2 FY27 with its highest-ever quarterly total income and improved working capital efficiency, though margin pressures persisted due to elevated raw material and freight costs. Evidence summary ready | |
| BLS BLS International Services Limited Services · Small | Sept 2026 4 Nov 2026 Preliminary brief | Average 42/100 | Optimistic outlook No comparable prior call New guidance | BLS International Services Limited reported a strong set of results for Q2 & H1 FY27, backed by robust revenue growth of 32.0% YoY to Rs. 972.7 Crores and PAT growth of 8.6% YoY to Rs. 202.7 Crores. Management outlined a clear FY30 vision targeting Rs. 6,300 - 6,500 Crores in revenue while maintaining an asset-light, tech-led model. Evidence summary ready | |
| ONIDA Onida Electronics Limited Industrials · Small | Sep 2026 4 Nov 2026 Preliminary brief | Average 32/100 | Optimistic outlook No comparable prior call No measurable guidance | While Onida is executing well on its Onida Rewired transformation—evidenced by robust 65% brand revenue growth, a 239% surge in air conditioner sales, and e-commerce channel expansion—profitability remains under intense stress. Gross margin pressures from geopolitical component cost inflation and surging operating expenses drove a net loss of Rs. 39.8 crores in Q2 FY27, highlighting execution risk in scaling margins alongside top-line growth. Evidence summary ready | |
| MPSLTD MPS Limited IT · Small | Sep 2026 4 Nov 2026 Preliminary brief | Bad 15/100 | Optimistic outlook No comparable prior call No measurable guidance | The investment thesis remains intact. MPS is delivering strong operating leverage, scaling research margins via AI adoption, integrating Unbound Medicine successfully, and maintaining zero debt with healthy cash flows. Evidence summary ready | |
| QUESS Quess Corp Limited Services · Micro | Sept 2026 4 Nov 2026 Transcript verified | Good 67/100 | Optimistic outlook No comparable prior call Guidance maintained | Quess Corp delivered a resilient performance in Q2 FY27, marked by 15% YoY revenue growth and a 44% surge in PAT, supported by robust associate additions and disciplined cash collections crossing INR 5,000 crores. Evidence summary ready | |
| JGCHEM J.G.Chemicals Limited Industrials · Small | Sept 2026 4 Nov 2026 Preliminary brief | Excellent 100/100 | Optimistic outlook No comparable prior call No measurable guidance | The investment thesis remains intact. Capacity utilisation is robust at over 80%, margin profile is expanding despite cost headwinds, and ongoing expansion projects in Dahej and Naidupeta are progressing on schedule to drive future growth and higher non-rubber revenue contributions. Evidence summary ready | |
| ZENSARTECH Zensar Technologies Limited IT · Small | Sep 2026 4 Nov 2026 Preliminary brief | Good 55/100 | Optimistic outlook No comparable prior call No measurable guidance | Zensar Technologies delivered a solid Q2FY27 with a 4.1% sequential constant currency revenue growth and an EBITDA margin expansion of 120 bps to 15.8%, driven by strong execution and robust volume momentum across key regions and verticals like BFSI. Evidence summary ready | |
| RUSTOMJEE Keystone Realtors Limited Real Estate · Small | Sep 2026 4 Nov 2026 Preliminary brief | Excellent 100/100 | Neutral outlook No comparable prior call No measurable guidance | The investment thesis remains intact as the company achieved 41% of its full-year FY27 pre-sales guidance in H1, supported by robust luxury segment traction and scaling cluster redevelopments. Balance sheet leverage remains conservative with a net D/E of 0.04:1. Evidence summary ready | |
| SUBEXLTD Subex Limited IT · Small | Sep 2026 4 Nov 2026 Preliminary brief | Excellent 100/100 | Optimistic outlook No comparable prior call No measurable guidance | The investment thesis is intact as revenue growth acceleration, strong annuity revenue proportion, positive EBITDA margins, and robust cash generation continue to play out per management targets. Evidence summary ready | |
| CHOLAFIN Cholamandalam Investment and Finance Company Limited Financial Services · Large | Sept 2026 4 Nov 2026 Transcript verified | Excellent 85/100 | Optimistic outlook No comparable prior call Guidance maintained | Cholamandalam Investment and Finance Company Limited reported a strong Q2 FY27 with broad-based growth across vehicle finance, SME, and consumer loans, achieving robust asset growth, improved return profiles, and stable credit quality. Evidence summary ready | |
| TRANSRAILL Transrail Lighting Limited Industrials · Micro | Sep 2026 4 Nov 2026 Preliminary brief | Average 52/100 | Bullish outlook No comparable prior call No measurable guidance | The investment thesis remains intact, supported by strong revenue growth, healthy operating margins, improving working capital discipline, and capacity expansions across towers and conductors aligning with India's transmission super-cycle. Evidence summary ready | |
| GOKULAGRO Gokul Agro Resources Limited FMCG · Micro | Sept 2026 4 Nov 2026 Transcript verified | Excellent 90/100 | Optimistic outlook No comparable prior call No measurable guidance | Gokul Agro Resources Limited reported a strong set of results for Q2FY27 with revenue of Rs. 7,481 crore and PAT of Rs. 146.2 crore, backed by improved realizations, sourcing discipline, and a expanding value-added and B2C product portfolio. Evidence summary ready | |
| FRACTAL Fractal Analytics Limited IT · Small | Sep 2026 4 Nov 2026 Preliminary brief | Excellent 90/100 | Optimistic outlook No comparable prior call No measurable guidance | Fractal Analytics reported a milestone first-ever $100m+ revenue quarter in Q2 FY27 with 19.9% YoY revenue growth and a 140.0% increase in Net Income, driven by operating leverage, despite a 225 bps contraction in gross margins due to talent investments. Evidence summary ready | |
| RUSHIL Rushil Decor Limited Industrials · Small | Sept 2026 4 Nov 2026 Preliminary brief | Excellent 77/100 | Bullish outlook No comparable prior call No measurable guidance | The investment thesis remains intact as capacity utilization rates improve across core segments, particularly MDF at 87% and Jumbo Laminates reaching 41%. Strong domestic demand offset temporary export caution, while improving realization mix supported margin recovery. Evidence summary ready | |
| MAPMYINDIA C.E. Info Systems Limited IT · Large | Sep 2026 4 Nov 2026 Preliminary brief | Excellent 90/100 | Optimistic outlook No comparable prior call No measurable guidance | C.E. Info Systems Limited delivered profitable growth in Q2 FY2027, driven by strong performance in the Automotive and Enterprise segments, which was partially offset by a decline in Government revenue due to a high base effect. Evidence summary ready | |
| PNGSREVA PNGS Reva Diamond Jewellery Limited Consumer · Small | Sept 2026 4 Nov 2026 Preliminary brief | Excellent 90/100 | Optimistic outlook No comparable prior call No measurable guidance | The investment thesis remains intact. Strong revenue growth, margin expansion, and scaling through new store openings and digital channel expansion demonstrate solid execution of the asset-light retail model. Evidence summary ready | |
| APARINDS Apar Industries Limited Industrials · Large | Sept 2026 4 Nov 2026 Transcript verified | Excellent 100/100 | Optimistic outlook No comparable prior call Guidance maintained | Apar Industries reported robust revenue and PAT growth in Q2 FY27, driven by strong domestic transmission demand and operational efficiency, although near-term volume growth was constrained by raw material inflation and shipping delays. Evidence summary ready | |
| SHALBY Shalby Limited Pharma · Small | Sep 2026 4 Nov 2026 Preliminary brief | Average 32/100 | Neutral outlook No comparable prior call No measurable guidance | The core hospital business maintains steady operational metrics and bed capacity expansion, but consolidated profitability remains under pressure due to losses in Shalby International (PK Healthcare) and Shalby MedTech. ROCE remains low at 6.6%, failing to capture full operating leverage. Evidence summary ready | |
| VARROC Varroc Engineering Limited Auto · Micro | Sept 2026 4 Nov 2026 Preliminary brief | Bad 2/100 | Optimistic outlook No comparable prior call No measurable guidance | Varroc Engineering delivered strong consolidated revenue growth of 33.6% YoY to Rs. 2,947.9 crore in Q2 FY27, supported by robust performance in both India (up 29.5%) and overseas operations (up 104.1%). However, profitability was pressured by unrecovered war-related inflation (impacting margins by ~80 bps) and restructuring costs in the Italy 2W lighting business, resulting in a 46.9% YoY drop in PAT to Rs. 33.5 crore. Evidence summary ready | |
| JISLDVREQS Jain Irrigation Systems Limited Industrials · Small | Sept 2026 4 Nov 2026 Preliminary brief | Pending data 0/100 | Optimistic outlook No comparable prior call No measurable guidance | The core investment thesis remains intact. While adverse weather and higher polymer costs pressured domestic margins and volumes, overseas segments and agro-processing delivered strong expansion. Aggressive working capital rationalisation and receivables collection drove strong operating cash flow to service debt and reduce 0.01% NCDs. Evidence summary ready | |
| JISLJALEQS Jain Irrigation Systems Limited Industrials · Small | Sept 2026 4 Nov 2026 Preliminary brief | Average 47/100 | Optimistic outlook No comparable prior call No measurable guidance | The investment thesis remains intact as overseas markets and agro-processing drive top-line growth, and working capital improvements enable debt reduction, despite temporary domestic headwinds from adverse weather and higher input costs. Evidence summary ready | |
| BANKBARODA Bank of Baroda Financial Services · Large | Sept 2026 4 Nov 2026 Transcript verified | Good 70/100 | Optimistic outlook No comparable prior call Guidance raised | Bank of Baroda reported its highest-ever quarterly operating profit and net profit for Q2 FY27, driven by strong RAM advances, robust deposit growth, and a significant one-off gain from the NSE stake sale, alongside proactive prudential provisioning for ECL migration. Evidence summary ready | |
| EPACK EPACK Durable Limited Consumer · Small | Sept 2026 4 Nov 2026 Transcript verified | Average 45/100 | Optimistic outlook No comparable prior call No measurable guidance | EPACK Durable reported strong top-line growth of 106.3% YoY in Q2 FY27 with revenue at INR 439.3Cr, supported by healthy secondary sales in room air conditioners and expansion in small/large domestic appliances. However, profitability remained under pressure with a net loss of INR 25.1Cr and an OPM of 1.6%, impacted by a forex loss of INR 10Cr, depreciation and interest costs from new capacities, and the absence of PLI income. Evidence summary ready | |
| GANESHHOU GANESH HOUSING LIMITED Real Estate · Small | Sep 2026 4 Nov 2026 Transcript verified | Bad 0/100 | Optimistic outlook No comparable prior call Guidance maintained | Ganesh Housing Limited reported a sequential recovery in Q2 FY27 margins and PAT after addressing previous-quarter high-cost basis and one-time tax charges, while reaffirming its full-year guidance backed by upcoming project completions and ongoing leasing momentum at its Million Minds IT campus. Evidence summary ready | |
| AMANTA Amanta Healthcare Limited Pharma · Small | Sept 2026 4 Nov 2026 Preliminary brief | Excellent 77/100 | Optimistic outlook No comparable prior call No measurable guidance | Amanta Healthcare reported strong Q2 FY27 performance with revenue of 83.1Cr and PAT of 4.9Cr, driven by capacity expansion such as SteriPort Line 3 and ongoing cost optimization through captive solar integration. Evidence summary ready | |
| INDIGO InterGlobe Aviation Limited Services · Large | Sept 2026 4 Nov 2026 Transcript verified | Average 45/100 | Optimistic outlook No comparable prior call Guidance maintained | IndiGo reported a net loss of INR 18.79 billion for Q2 FY27 due to exceptionally high jet fuel prices (with Singapore jet fuel index up 60% YoY) and rupee depreciation, despite delivering robust revenue growth and a 31% increase in PRASK. Management has taken decisive actions, including capacity rationalization and the conclusion of widebody damp-lease operations, while maintaining a strong liquidity position and an optimistic outlook on long-term Indian aviation demand. Evidence summary ready | |
| ACEVECTOR AceVector Limited Consumer · Micro | Sept 2026 4 Nov 2026 Preliminary brief | Average 32/100 | Optimistic outlook No comparable prior call No measurable guidance | The thesis remains intact as core operational metrics show healthy volume growth, with Snapdeal fashion NMV up 31% YoY and app-delivered units up 23% YoY, while Unicommerce maintains double-digit revenue growth and enterprise client additions. Margin pressures in H1 are explicitly attributable to front-loaded festive marketing and temporary logistics headwinds that eased sequentially in Q2. Evidence summary ready | |
| ARIS Arisinfra Solutions Limited Industrials · Small | Sept 2026 4 Nov 2026 Preliminary brief | Excellent 100/100 | Optimistic outlook No comparable prior call Guidance maintained | Arisinfra Solutions reported strong financial performance for Q2 FY27, featuring record-high quarterly PAT of Rs 22.8 Cr and an EBITDA margin of 11.6%, alongside improving working capital efficiency and robust growth in its Developer as a Service (DaaS) and contract manufacturing segments. Evidence summary ready |